Main Media English

Get Latest News, India News, World News at Main Media English

Support Us

Individual’s immune response to Covid virus may determine vax efficacy

IANS logo Reported By IANS |
Published On :

Tokyo, Nov 13 (IANS) Researchers have found that individual immune responses to the SARS-CoV-2 virus, particularly in mutant strains, can influence the efficacy of Covid-19 vaccines.

Efforts to contain the Covid-19 pandemic have largely focused on vaccine development and deployment.

Also Read Story

Empty chairs, forced attendance allegations cast shadow on INDIA bloc’s Delhi rally

Nagaland’s sole LS seat to witness triangular contest in 2024 polls

Odisha Crime Branch busts racket involved in Rs 1.04 cr fraud

IPL 2024: Under-pressure Mumbai Indians hope to shine in home comfort (Preview)

IPL 2024: Sai Sudharsan, David Miller star as clinical Gujarat beat Hyderabad by seven wickets

Viksit Bharat Ambassador meet-up: India is world’s 3rd largest start-up ecosystem today, says I&B Minister Anurag Thakur

Amit Shah chairs meeting of Lok Sabha core committees in Jaipur, holds roadshow in Sikar

IPL 2024: Ishant Sharma back as Delhi Capitals win toss, elect to bat against CSK

Viksit Bharat Ambassador Jaipur meet-up: Participants heap praise on the initiative

But how exactly do our immune systems respond to Covid-19 vaccines?


The major response occurs in one of two ways: the production of antibodies that bind to the receptor-binding domain (RBD) or the production of antibodies that bind to the N-terminal domain (NTD) of the coronavirus viral spike protein.

Both play important roles in preventing infection, pathogenesis, and severe disease.

However, the antibody repertoire varies widely among individuals.

While it has been suggested that this diversity in antibodies influences the ability to protect against mutant strains, its full extent has not been clear.

A team led by Osaka Metropolitan University researchers gained insight into the role of antibodies produced by vaccination in preventing infections, particularly in mutant strains of the coronavirus.

“The results of this study have demonstrated that understanding the nuances of antibody response to vaccination is critical for vaccine development,” said Mayo Yasugi, an Associate Professor at the Graduate School of Veterinary Science at Osaka.

“We believe our findings will provide a foundation for improved vaccine development in the future,” Yasugi added. The study, published in the journal Vaccine, focused on blood samples taken from volunteers 17 to 28 days post-2nd vaccination, a crucial period when antibody production peaks.

By examining the repertoire of antibodies produced by each individual, the researchers showed that antibodies could be categorised into three types, each targeting distinct regions of the viral spike protein, a key component of the vaccine antigen.

Furthermore, the study found that antibodies that primarily target NTD have a lower ability to protect against a delta variant of the coronavirus compared to those primarily targeting RBD.

Interestingly, the study also found that the presence or absence of infectivity-enhancing antibodies did not affect the ability of the antibodies to protect against variants.

–IANS

rvt/pgh

(This report is auto-generated from IANS news service. 'Main Media' holds no responsibility for its content.)

Get involved in bringing the ground realities of Seemanchal. Click the "Support Us" button to join our membership.

Support Us

Related News

Pawar vs Pawar: A fight for supremacy in Baramati

Rebel Wilson opens up on weight loss journey, says she’s an emotional eater

Shraddha Kapoor asks fans how they wasted 1st quarter of 2024

PM Modi virtually interacts with party workers in Varanasi

AIADMK will ally again with BJP after LS elections, says Chidambaram

PE-VC investments fall by 8 per cent to $6.2 billion in Q1

Cut! Mark Ronson’s role in Amy Winehouse biopic gets axed

Leave a Reply

Your email address will not be published. Required fields are marked *